The Nasdaq Biotechnology Index closed up 1.85%, outperforming both small-cap indices and the three major U.S. stock indices
Component stock Q32 Bio rose by 33.65%, Summit Therapeutics Plc. increased by 16.32%, and Iovance Biotherapeutics rose by 15.21%, ranking third. IGM Biosciences fell by 5.19%, ranking third from the bottom, Grail dropped by 5.37%, and Prime Medicine decreased by 5.83%
Source: Wallstreetcn The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments